IMRIS
- Industry
- Medical Devices
- Founded Year
- 2005
- Headquarters
- Chaska, Minnesota, USA
- Employee Count
- 0
Key People
- Marc Buntaine - Chief Executive Officer
- Gregory Sorensen - Executive Chairman
- Denis Sutton - Executive Vice President, Human Resources
- Kelly McNeill - Executive Vice President, Finance and Administration and Chief Financial Officer
- William Fraser - Director
- Steve Armstrong - Director
- James B. Hickey - Director
- Carey Diamond - Board Member
- H. David Graves - Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: IMRIS's leadership team comprises seasoned executives with extensive experience in the medical device industry.
The presence of multiple successful MedTech entrepreneurs in leadership positions provides IMRIS with a strong foundation for innovation and market penetration.
- Clinical Need
-
Aspect: Very Strong
Summary: IMRIS addresses a critical need for enhanced surgical precision in neurosurgery through intraoperative MRI solutions.
By enabling real-time imaging during surgery, IMRIS's solutions meet a vital clinical demand for accuracy and patient safety in complex neurosurgical procedures.
- Competition
-
Aspect: First mover
Summary: IMRIS is a pioneer in intraoperative MRI solutions, with limited direct competition in its specific niche.
As the first mover in ceiling-mounted, movable intraoperative MRI systems, IMRIS has established a strong market presence and brand recognition.
- Technical Challenge
-
Aspect: Very Complex
Summary: Developing and integrating movable intraoperative MRI systems involves significant technical complexity.
The intricate engineering required for IMRIS's systems necessitates substantial R&D investment and expertise, potentially impacting time-to-market and cost structures.
- Patent
-
Aspect: Very Strong
Summary: IMRIS holds robust patents protecting its innovative intraoperative MRI technologies.
The company's comprehensive patent portfolio safeguards its proprietary technologies, ensuring market exclusivity and supporting long-term growth.
- Financing
-
Aspect: Strategics
Summary: IMRIS is backed by strategic investors with a focus on healthcare and medical technologies.
While strategic partnerships can provide valuable resources, they may also lead to potential conflicts of interest or strategic misalignments.
- Regulatory
-
Aspect: 510k/PMA + Reimbursement
Summary: IMRIS's products have obtained necessary regulatory approvals and are eligible for reimbursement.
Achieving and maintaining regulatory compliance requires ongoing effort and can impact product launch timelines and market access.
Opportunity Rollup
- Odds of Success
- 3.4
- Peak Market Share
- 4.45
- Segment CAGR
- 2.9%
- Market Segment
- Diagnostic Imaging
- Market Sub Segment
- Intraoperative MRI Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.67 |
| 3 | 1.56 |
| 4 | 3.11 |
| 5 | 4.45 |
Key Takeaway
IMRIS's pioneering intraoperative MRI solutions address a critical clinical need, positioning the company for significant growth despite technical and regulatory challenges.